- Home
- NIO vs MEDP Comparison
NIO vs MEDP Comparison
Compare NIO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIO
- MEDP
- Stock Information
- Founded
- NIO 2014
- MEDP 1992
- Country
- NIO China
- MEDP United States
- Employees
- NIO N/A
- MEDP N/A
- Industry
- NIO Auto Manufacturing
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- NIO Consumer Discretionary
- MEDP Health Care
- Exchange
- NIO Nasdaq
- MEDP Nasdaq
- Market Cap
- NIO 8.1B
- MEDP 8.5B
- IPO Year
- NIO 2018
- MEDP 2016
- Fundamental
- Price
- NIO $3.41
- MEDP $309.36
- Analyst Decision
- NIO Hold
- MEDP Hold
- Analyst Count
- NIO 7
- MEDP 10
- Target Price
- NIO $4.90
- MEDP $343.22
- AVG Volume (30 Days)
- NIO 33.6M
- MEDP 344.5K
- Earning Date
- NIO 06-03-2025
- MEDP 07-21-2025
- Dividend Yield
- NIO N/A
- MEDP N/A
- EPS Growth
- NIO N/A
- MEDP 33.36
- EPS
- NIO N/A
- MEDP 13.09
- Revenue
- NIO $9,351,292,224.00
- MEDP $2,156,580,000.00
- Revenue This Year
- NIO $39.75
- MEDP $5.64
- Revenue Next Year
- NIO $26.49
- MEDP $3.32
- P/E Ratio
- NIO N/A
- MEDP $23.59
- Revenue Growth
- NIO 23.71
- MEDP 9.87
- 52 Week Low
- NIO $3.02
- MEDP $250.05
- 52 Week High
- NIO $7.71
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- NIO 36.71
- MEDP 55.79
- Support Level
- NIO $3.49
- MEDP $294.07
- Resistance Level
- NIO $3.90
- MEDP $304.69
- Average True Range (ATR)
- NIO 0.13
- MEDP 9.68
- MACD
- NIO -0.02
- MEDP 0.72
- Stochastic Oscillator
- NIO 9.65
- MEDP 66.62
About NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.